52 followers
CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boy. https://t.co/0tG6zViqKv https://t.co/bt75mXA8xq
CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boy. https://t.co/0tG6zViqKv https://t.co/bt75mXA8xq
#PediatricPulmonology CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boy https://t.co/br8ppiczlO